Inflammatory biomarkers, such as C-reactive protein (CRP) and interleukin-6 (IL-6), serve as indicators of the inflammatory state and have the potential to aid in predicting the likelihood of developing diabetes and experiencing cardiovascular complications. Here, IL6 is linked to diabetes mellitus.